广州医药 ›› 2023, Vol. 54 ›› Issue (3): 30-34.DOI: 10.3969/j.issn.1000-8535.2023.03.006

• 论著 • 上一篇    下一篇

母细胞性浆细胞样树突细胞肿瘤临床病理特征分析

李春艳1,2, 方雅兰1,3, 刘国荣1, 常丽君1, 陈少红1, 丁文双1   

  1. 1 广州市第一人民医院,华南理工大学第二附属医院病理科(广州 510180)
    2 南方医科大学附属茂名医院病理科(茂名 525000)
    3 珠海市妇幼保健院病理科(珠海 519000)
  • 收稿日期:2022-05-30 出版日期:2023-03-20 发布日期:2023-04-14
  • 通讯作者: 丁文双,E-mail:008ding@163.com

Analysis of clinicopathological features of blastic plasmacytoid dendritic cell neoplasm and literature review

LI Chunyan1,2, FANG Yalan1,3, LIU Guorong1, CHANG Lijun1, CHEN Shaohong1, DING Wenshuang1   

  1. 1 Department of Pathology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510180, China
    2 Department of Pathology, Affiliated Maoming Hospital of Southern Medical University, Maoming 525000, China
    3 Department of Pathology, Zhuhai Center for Maternal and Child Health Care, Zhuhai 519000, China
  • Received:2022-05-30 Online:2023-03-20 Published:2023-04-14

摘要: 目的 学习母细胞性浆细胞样树突细胞肿瘤(BPDCN)的临床病理及免疫表型特征,总结该少见肿瘤的病理诊断经验。方法 回顾分析2例BPDCN患者临床资料,通过苏木素-伊红(HE)染色分析肿瘤组织及细胞形态,通过免疫组织化学染色分析肿瘤免疫表型,通过流式细胞学检测骨髓有无肿瘤侵犯,并结合文献分析。结果 本报道中1例为97岁女性,临床以皮肤瘀斑结节为首发症状,肿瘤细胞真皮内弥漫浸润,不侵犯表皮,细胞中等大小,核形不规则,核仁不明显。另1例为69岁男性,临床以淋巴结肿大为首发症状,淋巴结结构完全破坏,肿瘤细胞弥漫浸润,细胞呈中等大小的母细胞样,核仁明显。2例免疫表型均表达CD123、CD4、CD56、TDT,不表达B系、T系淋巴细胞及髓系标志物,肿瘤均累及骨髓。结论 BPDCN是一种罕见的淋巴造血肿瘤,临床常以皮肤病变或淋巴结肿大为首发症状,临床过程具高度侵袭性,通常伴有骨髓侵犯。该肿瘤需与具有母细胞形态的淋巴系肿瘤和白血病相鉴别,诊断需结合临床信息、HE形态及免疫组化结果综合判断。

关键词: 母细胞性浆细胞样树突细胞肿瘤, 皮肤, 淋巴结, 免疫表型

Abstract: Objective To summarize the diagnostic experiences of blastic plasmacytoid dendritic cell neoplasm (BPDCN) based on the study of its clinicopathological features and immunophenotypes. Methods The clinical data of 2 patients with BPDCN were collected, the structure alteration and cell morphology were observed by HE staining, the immunophenotype of tumor cells were studied by immunohistochemistry staining and flow cytometry was adopted to confirm the bone marrow involvement. Results Two patients, one of whom was a 97 year-old female, presented with cutaneous ecchymosis nodules as the first symptom. The epidermis, but not the dermal, was diffusedly infiltrated by tumor cells, which were medium-sized with irregular nuclei without prominent nucleoli. The other case was a 69 year-old male with lymph node enlargement as the first symptom. The skin was normal, but the lymph nodes were invasively destroyed by tumor cells, which were medium-sized blast-like with prominent nucleoli. The immunophenotypes of the two patients were both positive for CD123, CD4, CD56 and TDT, but negative for B, T lymphocyte derived and myeloid origin markers, both of which involved bone marrow. Conclusions BPDCN is a rare form of hematological neoplasm, skin symptoms or lymph node enlargement may be presented as the initial symptom, the clinical course were highly aggressive with high frequency of bone marrow involvement. The blastic-like lymphoma and leukemia entities should be considered into account for differential diagnose. The precise diagnosis of BPDCN should be established by integrating histomorphology, immunophenotype and clinical presentation information comprehensively.

Key words: blastic plasmacytoid dendritic cell tumor, skin, lymph node, immunophenotype